HKG:1177 Sino Biopharm
HKG:1177 Sino Biopharm operates in the field of Medicine. The Group’s business works in a fully integrated chain which spans from R&D to manufacture and sales of pharmaceutical products, covering a vast array of biopharmaceutical, chemical and modernized Chinese medicines. Interim result 2022 are favorable for dividends (+200%) yet EPS fell 77%
HKG:1177 Sino Biopharm
Last update: 3-Aug-24
Quick overview:
- Yield: 1.79%
(See here Top 10 highest yield)
- Lot: 1000
- Price/Earnings ratio : 23.33 (Ideal <20 )
- Earnings per share : 0.120 (Ideal >0.001)
- Price as per 3-Aug-24 : HK$2.80
- Ex-Dividend Date coming up: N/A
See here all upcoming Ex-Dividend dates
2024 Interim results: 0
Log in, to see this page |
Sign up for freeand get immediate access to |
|
YES, FOR FREE We promise to only send you amazing helpful emails! |